Mehr Wissen: Werden LSD und andere Psychedelika Medikamente?

Moderation: Prof. Raphael Guzman Head of Neurosurgery, University Hospital Basel PD Dr. Felix Müller Clinical Research Unit for Substance-Assisted Therapy, University Psychiatric Clinics Basel Prof. Matthias Liechti Department of Clinical Pharmacology, University Hospital Basel Recorded on Thursday, March 16, 2023 More Knowledge – The Public Lecture Series of the University Hospital Basel Brain Week 2023 https://www.neuronetwork.unibas.ch/br... 00:00:00 Introduction, Prof. Dr. Raphael Guzman 00:02:54 The Discovery of LSD by Albert Hofmann 00:05:39 Psychedelics as Medications? Prof. Dr. Matthias Liechti 00:06:12 The Renaissance of Psychedelics 00:07:06 Studies with Psychoactive Substances in Patients 00:13:00 Why Psychedelics? 00:14:55 The History of LSD 00:18:15 The Discovery of Psilocybin 00:20:06 Consciousness 00:22:06 How Does It Work? 00:26:31 Is LSD Dangerous? (Relative Harm of Drugs) 00:29:34 Studies in Basel 00:33:44 Transition to PD Dr. Felix Müller 00:34:46 Hallucinogens in Mental Illness, PD Dr. Felix Müller 00:35:02 Discovery and market launch of LSD and psilocybin 00:37:19 Research methodology of the 1950s and 60s 00:43:50 End of use and research in the early 1970s 00:45:21 Current research: Psilocybin for alcohol addiction 00:47:58 Mechanisms of action 00:51:48 LSD Assist Studio 00:59:43 Research with hallucinogens: Open questions 01:03:35 Q&A: LSD - special situation in Switzerland 01:03:16 Q&A: Dosage for chronic illnesses 01:05:05 Q&A: Why is psilocybin more frequently researched than LSD? 01:06:48 Q&A: Different types of psilocybin and LSD 01:08:25 Q&A: What is the purpose of microdosing? 01:13:43 Q&A: Combining different substances 01:16:19 Q&A: How long can an LSD treatment last, and are there any side effects? 01:19:39 Q&A: How does LSD/psilocybin treatment come about?